We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Blesses Roche’s Advanced Melanoma Drug in Combination with Zelboraf
FDA Blesses Roche’s Advanced Melanoma Drug in Combination with Zelboraf
Roche’s Genentech unit and partner Exelixis scored a regulatory win Tuesday, with the FDA approving Cotellic as part of combination treatment for advanced melanoma.